This website uses cookies to enhance the user experience.
A

ALGIPHARMA AS964 911 444

Research
Limited company
Industriveien 33 1337 SANDVIKA, Norge

ALGIPHARMA AS

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

Chairman of the board
Years since formation
29 years
since Feb 20, 1995
Type
Limited company
VAT registered
Yes
Number of employees
6

Ownership

Number of shares and share classes
5,663,403
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2023
85,940
NOK
Annual total result 2023
-9,715,740
NOK
Total equity 2023
128,587,961
NOK
Last update: Nov 14, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
73.76 %
indirectly

Board

NameRoleShares
Chairman
1.86 %
indirectly
Board Member-
Board Member
73.76 %
indirectly

Others

NameRoleShares
D
DELOITTE AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Board Member
73.76 %
indirectly
-
13.46 %
indirectly
Chairman
1.86 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
A
ALGIPHARMA HOLDING AS
Ordinary shares
5,663,403
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -154,066
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
85,940
40,000
64,500
Annual Total Result
-9,715,740
-7,073,262
-10,657,673
Total assets
188,878,585
173,350,922
155,526,168
Total liabilities
60,290,624
145,462,676
120,564,660
Total equity
128,587,961
27,888,246
34,961,508

P&L

Year202320222021
Total operating income
85,940
40,000
64,500
Total operating costs
5,929,616
7,984,794
6,701,441
Operating result
-5,843,676
-7,944,794
-6,636,941
Financial income/costs
-3,987,833
871,531
-4,020,732
Profit before tax
-9,831,509
-7,073,262
-10,657,673
Total tax & extraordinary income/cost
-115,769
0
0
Annual Total Result
-9,715,740
-7,073,262
-10,657,673

Balance overview

Year202320222021
Total fixed assets
181,567,841
168,449,203
149,488,068
Total current assets
7,310,744
4,901,720
6,038,100
Total assets
188,878,585
173,350,922
155,526,168
Short term debt
12,624,763
17,695,462
8,304,754
Long term debt
47,665,861
127,767,215
112,259,905
Total liabilities
60,290,624
145,462,676
120,564,660
Contributed capital
128,587,961
27,888,246
34,961,508
Retained earnings
0
0
0
Total equity
128,587,961
27,888,246
34,961,508
Total equity and liabilities
188,878,585
173,350,922
155,526,168

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering